Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
3 Months Ended 169 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Revenues:      
Grant revenue $ 200,400 $ 554,600 $ 12,963,100
Collaboration revenue       2,283,600
Other       1,123,500
Total revenues 200,400 554,600 16,370,200
Operating expenses:      
Research and development 866,300 1,027,900 26,991,200
Acquired in-process research and development       7,523,200
General and administrative 1,055,300 1,126,600 28,173,700
Total operating expenses 1,921,600 2,154,500 62,688,100
Loss from operations (1,721,200) (1,599,900) (46,317,900)
Other expenses, net:      
Interest expense, net (102,800) (731,600) (9,544,300)
Change in put and note extension option and warrant liabilities    (78,000) 418,500
Loss on early extinguishment of debt       (1,193,500)
Other income       47,500
Loss before income taxes (1,824,000) (2,409,500) (56,589,700)
Income taxes (1,900) (1,600) (18,700)
Net loss (1,825,900) (2,411,100) (56,608,400)
Basic and diluted net loss per common share $ (0.11) $ (0.22)  
Weighted average shares used in computing basic and diluted net loss per common share 16,842,655 11,105,854  
Comprehensive loss $ (1,825,900) $ (2,411,100) $ (56,608,400)